goodphyte™ — Northern Nutrition: Evidence & Voices

Voices From the Field

Real People, Real Results

The mechanisms below are established in the literature. These are the people who feel them day to day — endurance athletes, a firefighter, a coach — describing, in their own words, what changed after they started taking the enzyme with their food. Each account links to its original post, episode, or clip so it can be verified directly. (The product was previously sold as Access Nutrients and is now Goodphyte; earlier testimonials use the former name.)

Firefighter · Endurance Athlete

“As a father, firefighter and endurance athlete it is important to stay healthy and take care of myself… I've only been taking it for a month now and am surprised at how much more sustained energy I have throughout the day. I used to have mid-day crashes of fatigue and that has stopped. My energy and alertness are consistent day to day and my runner's gut has settled down.”

Devin FeatherstoneUltra-endurance athlete, firefighter and father

Instagram post

Olympic Marathon Trials Qualifier

“Goodphyte is such a great tool to enable you to be ready every day, to put in the work. It's not just another supplement you're adding to the top of your list — it's enabling you to absorb the nutrients in the healthy whole foods you already eat.”

Rebecca SchmittElite marathoner · 1:10:10 half-marathoner & 2028 U.S. Olympic Marathon Trials qualifier

Full episode Short: not just another supplement Instagram post

Elite Marathoner

“In taking Goodphyte, I haven't had any bone issues, stress fractures — my immunity's been better, my energy levels have been better. I did not get sick after this last half-marathon, and I get sick after almost every race.”

Rebecca SchmittElite marathoner · U.S. Olympic Marathon Trials qualifier

Short: no stress fractures Short: didn't get sick

USATF National Champion

“Taking the morning fasted, even just one or two Goodphytes, felt like it lowered just the cost of admission from maybe a five out of 10 to maybe even a three or four out of 10 — to just jog around and just get the miles done, even if I'm exhausted.”

Anthony KunkelUSATF 50-Mile & 100K National Champion · Team USA 100K

Full episode Short: overcoming barriers Short: phytase & phytic acid Instagram post

Elite Ultra & Trail Runner

“I'm inexplicably fast right now — a monster running up hills, and I'm recovering fast. My 100-mile week didn't ruin me. Effort feels good; it doesn't feel as draining as it normally would.”

Alyssa TurnerElite ultra & trail runner · @lyssakturner

Full episode Short: fitness boost Instagram post

Elite Running Coach · Rheumatoid Arthritis

Sandra, an elite running coach living with rheumatoid arthritis, had been sleeping ten to twelve hours a night plus two-to-four-hour afternoon naps during a flare. After adding phytase to her routine, the naps dropped out entirely. “I haven't had a nap for a long time now since taking phytase… that's been a huge change.”

Sandra YaworskiElite running coach living with rheumatoid arthritis · @sandrayaworskitraining

Full episode Short: energy & brain fog Instagram post

Distance Runner

“I'd struggled with low iron for years. I'd regularly need naps before my training runs just to have enough energy… A few weeks after taking the supplement with my food I noticed an increase in energy and my running performance improved as well. I recently ran the Mississauga Marathon and achieved a 58-minute personal best.”

Distance runnerShared on Instagram · @motivated.mrs

Instagram post

Trail & Ultra Runner

“My energy had been severely lacking for six months… I started taking it and noticed the change within two weeks. I wasn't groggy in the morning and felt rested, my body seemed to respond better to clean foods (no bloat)… My energy is now at least 8 out of 10. I finally feel like I'm getting my feet back under me.”

Kara LeinweberTrail/ultra runner and race director

Instagram post

Why this matters in the North. These accounts describe the same physiology the proposal rests on — sustained energy, faster recovery, fewer fatigue crashes, and better sleep — in people under real training and work load. The firefighter and national-champion endurance accounts map most directly onto the operational-readiness case; the everyday-energy accounts map onto the community-health case.

Part I

The Phytic-Acid Problem: How It Blocks Absorption

Phytic acid — myo-inositol hexakisphosphate (IP6), the plant storage form also termed phytate — is the dominant anti-nutrient in whole grains, legumes, nuts, seeds, and the flours, breads, pastas, cereals, and ration and meal-replacement bars made from them. It chelates divalent mineral cations (iron, copper, zinc, magnesium, calcium) in the gastrointestinal tract, forming insoluble complexes that are excreted rather than absorbed. Humans lack sufficient endogenous phytase to degrade it, which is why an exogenous phytase such as Goodphyte can restore mineral bioavailability from the same food.

Sandberg A-S. (2002). Bioavailability of minerals in legumes. British Journal of Nutrition, 88(S3):S281–S285. Open article

Establishes that phytic acid in plant foods acts as the primary anti-nutrient limiting iron, zinc, calcium, and magnesium absorption in legume-dominant diets. Foundational reference for the phytic-acid–mineral binding mechanism.

Hallberg L, Brune M, Rossander L. (1989). Iron absorption in man: ascorbic acid and dose-dependent inhibition by phytate. American Journal of Clinical Nutrition, 49(1):140–144. Open article

Classic human absorption study demonstrating that phytic acid inhibits iron absorption in a dose-dependent manner. Removing it from bran substantially increased iron bioavailability — the core mechanistic evidence behind the proposal's central claim.

Brouns F. (2022). Phytic acid and whole grains for health controversy. Nutrients, 14(1):25. Open article

Comprehensive overview of phytic-acid chemistry, its linear inhibitory relationship with iron and zinc bioavailability as concentration rises, and the absence of human endophytase capacity. Confirms that the more a diet leans on grain- and seed-based staples, the greater the phytic-acid load.

Kumar V, Sinha AK, Makkar HPS, Becker K. (2010). Dietary roles of phytate and phytase in human nutrition: a review. Food Chemistry, 120(4):945–959. Open article

Review covering phytic acid's simultaneous binding affinity for multiple minerals — iron, zinc, magnesium, calcium, and phosphorus — and the broader case for exogenous phytase supplementation to restore mineral bioavailability. Provides the foundational mechanistic context for the multi-mineral chelation claims.

Part II

The Four-Pillar Framework

Pillar 01

Skeletal Resilience & Macro-Mineral Availability

Bone maintenance under load — rucking and patrol for personnel, growth in children and bone preservation in Elders across a community — requires consistent calcium and phosphorus delivery at digestion, meal after meal. When phytic acid blocks these minerals, bone mineralization runs at a deficit regardless of intake numbers.

Troesch B, Egli I, Zeder C, Hurrell RF, de Pee S, Zimmermann MB. (2013). Absorption studies show that phytase from Aspergillus niger significantly increases iron and zinc bioavailability from phytate-rich foods. Food and Nutrition Bulletin, 34(2 Suppl):S90–S101. Open article

Key systematic review of human absorption studies demonstrating that phytase clearly improves iron and zinc bioavailability, with documented potential to increase calcium, magnesium, and phosphorus absorption. Directly supports the claim that phytase frees macro-minerals for skeletal use.

Hambidge KM, Krebs NF, Westcott JL, Sian L, Miller LV, Peterson KL, Raboy V. (2005). Absorption of calcium from tortilla meals prepared from low-phytate maize. American Journal of Clinical Nutrition, 82(1):84–87. Open article

Human study showing that reducing phytic-acid content in cereal-based meals significantly increases calcium bioavailability. Supports the mechanism by which phytase supplementation could preserve bone mineral density under repeated physiological load.

Bischoff SC, Barbara G, Buurman W, et al. (2014). Intestinal permeability — a new target for disease prevention and therapy. BMC Gastroenterology, 14:189. Open article

Provides the gut-barrier context: when intestinal permeability rises under sustained physical and schedule stress, systemic inflammatory load increases, which is increasingly recognized as a contributor to bone stress events. Supports the pillar's broader resilience framing.

Pillar 02

Iron, Oxygen, Energy & Recovery

Iron, copper, zinc, and magnesium each govern a distinct pathway for oxygen delivery, energy, and recovery. Subclinical depletion — not clinical deficiency — is the quiet cost, because it accumulates invisibly across a long deployment or a hard Northern winter.

Zimmermann MB, Hurrell RF. (2007). Nutritional iron deficiency. The Lancet, 370(9586):511–520. Open article

Authoritative review distinguishing subclinical iron depletion (impaired aerobic capacity, fatigue, reduced work output) from clinical anaemia. The claim that subclinical depletion — not anaemia — is the operative variable is grounded directly in this literature.

Sandberg AS, Hulthén LR, Türk M. (1996). Dietary Aspergillus niger phytase increases iron absorption in humans. Journal of Nutrition, 126(2):476–480. Open article

Controlled human study demonstrating direct, measurable improvement in iron absorption when phytase was added to a phytic-acid–rich meal. One of the primary studies underlying the iron-bioavailability claim.

Prasad AS. (2008). Zinc in human health: effect of zinc on immune cells. Molecular Medicine, 14(5–6):353–357. Open article

Comprehensive review of zinc's role in immune function, hormonal signaling, and tissue repair. Supports the claim that phytic-acid–limited zinc affects immune resilience and recovery, not only during illness but through the ordinary repair cycle.

Abbasi B, Kimiagar M, Sadeghniiat K, et al. (2012). The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. Journal of Research in Medical Sciences, 17(12):1161–1169. Open article

Randomized controlled trial showing that magnesium supplementation improved sleep efficiency, sleep time, early-morning awakening, and insomnia severity. Direct evidence for the magnesium–sleep relationship developed under Pillars 02 and 04.

On absorption-improvement figures: multiple controlled phytase studies, reviewed in Troesch et al. (2013) above, report iron-absorption increases ranging from roughly 50% to well over 150%, depending on baseline phytic-acid load and food matrix. The upper range corresponds to high-phytic-acid meal scenarios consistent with ration- and staple-heavy Northern diets.

Pillar 03

Protein Utilization & Gut Integrity

Phytic acid complexes not only with minerals but with proteins and amino acids at the point of digestion, reducing net protein bioavailability. It also compromises gut-barrier integrity, raising systemic inflammatory load and slowing recovery.

Gilani GS, Cockell KA, Sepehr E. (2005). Effects of antinutritional factors on protein digestibility and amino acid availability in foods. Journal of AOAC International, 88(3):967–987. Open article

Systematic review confirming that phytic acid reduces true protein digestibility and limits amino-acid bioavailability. Supports the claim that a person eating adequate dietary protein may absorb significantly less at the tissue level due to phytic-acid interference.

Bischoff SC, Barbara G, Buurman W, et al. (2014). Intestinal permeability — a new target for disease prevention and therapy. BMC Gastroenterology, 14:189. Open article

Establishes that gut-barrier dysfunction under physiological stress elevates circulating endotoxin and systemic inflammatory markers. Supports the framing that gut integrity is a recovery variable, not only a gastroenterology concern.

Rondanelli M, Opizzi A, Monteferrario F, et al. (2011). The effect of melatonin, magnesium, and zinc on primary insomnia in elderly patients. Journal of the American Geriatrics Society, 59(1):82–90. Open article

Randomized placebo-controlled trial examining zinc, magnesium, and melatonin on sleep and recovery. Supports the framing that mineral bioavailability affects collagen synthesis and tissue repair through downstream sleep-quality effects.

Pillar 04

Metabolic Signaling: Inositol Liberation & IAP Activation

Pillar 04 is the emerging-science frontier. The mechanisms are established; both pathways — inositol liberation and intestinal alkaline phosphatase (IAP) activation — operate through conserved mammalian physiology.

Intestinal Alkaline Phosphatase (IAP)

Malo MS, Alam SN, Mostafa G, et al. (2010). Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut, 59(11):1476–1484. Open article

Demonstrates that IAP is essential for maintaining gut-microbiota homeostasis through nucleotide dephosphorylation and endotoxin detoxification. IAP-knockout animals showed dysbiosis and systemic inflammatory elevation.

Bates JM, Akerlund J, Mittge E, Guillemin K. (2007). Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in response to the gut microbiota. Cell Host & Microbe, 2(6):371–382. Open article

Mechanistic study showing that IAP dephosphorylates and detoxifies bacterial LPS (endotoxin) at the gut lumen, preventing inflammatory signaling to the systemic circulation.

Kaliannan K, Hamarneh SR, Economopoulos KP, et al. (2013). Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proceedings of the National Academy of Sciences, 110(17):7003–7008. Open article

Translational study showing that IAP limits endotoxin translocation and downstream inflammatory signaling. Supports the claim that IAP activity is germane to AMPK-pathway function and systemic energy metabolism.

Liu N, Ru YJ, Li FD. (2010). Effect of dietary phytate and phytase on metabolic change of blood and intestinal mucosa in chickens. Journal of Animal Physiology and Animal Nutrition, 94(3):368–374. Open article

The primary citation for the phytase–ALP relationship, recommended by Dr. Mike Bedford. In a controlled 2×3 factorial study, high-phytic-acid diets suppressed alkaline phosphatase activity in serum and intestinal mucosa (p<0.05), while phytase restored duodenal and jejunal ALP by 9–16% (p<0.05). Critically, ALP requires magnesium and zinc as cofactors — the same two minerals phytic acid most aggressively sequesters — so phytic acid delivers a compounded suppression that phytase resolves at both points. The study also documented phytic-acid–driven reductions in serum Fe, Cu, Zn, Mg, K, and P (4–14%, p<0.05), with phytase restoring them by 5–15%, confirming the multi-mineral scope of the anti-nutritional action.

Inositol Liberation & Metabolic Signaling

Croze ML, Soulage CO. (2013). Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie, 95(10):1811–1827. Open article

Comprehensive review of myo-inositol's roles in glucose transport, insulin signaling, and metabolic flexibility. When phytase hydrolyzes phytic acid fully, free inositol is liberated for these functions — a documented mechanism, not a speculative one.

Larner J. (2002). D-chiro-inositol — its functional role in insulin action and its deficit in insulin resistance. International Journal of Experimental Diabetes Research, 3(1):47–60. Open article

Establishes the mechanistic link between inositol phosphoglycan mediators and cellular glucose uptake — the pathway relevant to muscle and liver glycogen resynthesis during sustained high-output periods.

Part III

Immunity & Sleep in the Cold, Dark North

Immune Function — Zinc & Mucosal Immunity

Zinc governs mucosal immune function more directly than any other single micronutrient. Because phytic acid binds it tightly, people with apparently adequate dietary zinc may be functionally zinc-insufficient where it matters most — at the mucosal barrier. This turns acute through long, cold, low-light Northern winters, when respiratory infections spread hardest and fresh food is scarcest.

Prasad AS. (2008). Zinc in human health: effect of zinc on immune cells. Molecular Medicine, 14(5–6):353–357. Open article

Establishes zinc's essential role in NK-cell function, T-lymphocyte proliferation, and cytokine production. Zinc deficiency — including subclinical depletion — is associated with impaired mucosal immunity and increased susceptibility to upper-respiratory illness.

Hemilä H. (2011). Zinc lozenges may shorten the duration of colds: a systematic review. Open Respiratory Medicine Journal, 5:51–58. Open article

Systematic review of 13 trials on zinc's role in reducing common-cold duration. Relevant to the claim that improved zinc bioavailability shortens illness when infection does occur.

Directly supports the mechanism: phytase supplementation improves zinc absorption from the same foods already eaten, closing the gap between intake and bioavailability during extended field rotations and resupply gaps.

Sleep & Recovery — Magnesium, Melatonin, and Deep Sleep

The sleep evidence supports four claims: (1) magnesium is required for melatonin synthesis and deep slow-wave sleep; (2) sleep restriction produces measurable cognitive and neuromuscular deficits; (3) even partial sleep loss sharply reduces natural-killer-cell activity; and (4) growth hormone and muscle protein synthesis peak during deep slow-wave sleep. High-latitude light and sentry or shift rotations disrupt exactly this sleep, when magnesium is least available.

Abbasi B, Kimiagar M, Sadeghniiat K, et al. (2012). The effect of magnesium supplementation on primary insomnia in elderly. Journal of Research in Medical Sciences, 17(12):1161–1169. Open article

RCT showing magnesium supplementation significantly improved sleep efficiency, sleep time, insomnia severity, and early-morning awakening. Supports the claim that magnesium is a biochemical co-factor for sleep depth, not a sedative.

Rondanelli M, Opizzi A, Monteferrario F, et al. (2011). The effect of melatonin, magnesium, and zinc on primary insomnia in elderly. Journal of the American Geriatrics Society, 59(1):82–90. Open article

Placebo-controlled trial showing synergistic sleep improvements from a mineral–melatonin combination, with magnesium specifically required for melatonin biosynthesis. Supports the framing of magnesium as a rate-limiting co-factor for deep sleep.

Van Dongen HPA, Maislin G, Mullington JM, Dinges DF. (2003). The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep, 26(2):117–126. Open article

Landmark controlled study: adults restricted to 4 or 6 hours in bed for 14 nights showed cumulative, progressive decline in vigilance, working memory, and processing speed, reaching deficits equivalent to 1–2 nights of total sleep deprivation — while largely unaware of their impairment. Supports the late-deployment / late-winter drop-off pattern.

Durmer JS, Dinges DF. (2005). Neurocognitive consequences of sleep deprivation. Seminars in Neurology, 25(1):117–129. Open PDF

Comprehensive review documenting that sleep loss impairs psychomotor speed, vigilant attention, executive function, working memory, and decision-making — the functions most relevant to reaction time and situational awareness under fatigue.

Lowe CJ, Safati A, Hall PA. (2017). The neurocognitive consequences of sleep restriction: a meta-analytic review. Neuroscience & Biobehavioral Reviews, 80:586–597. Open article

Meta-analysis of 71 sleep-restriction studies (n=1,688) finding a moderate overall neurocognitive deficit (Hedges' g ≈ −0.38), largest in sustained attention and executive function. Quantifies the deficit at the population level.

Irwin M, Mascovich A, Gillin JC, Willoughby R, Pike J, Smith TL. (1994). Partial sleep deprivation reduces natural killer cell activity in humans. Psychosomatic Medicine, 56(6):493–498. Open article

Partial sleep deprivation (sleep restricted to the 3–7 AM window) reduced NK-cell lytic activity to 72% of baseline in 18 of 23 healthy men (p<0.01), recovering after one night of normal sleep. Underpins the “up to ~70% reduction” claim.

Irwin M, McClintick J, Costlow C, Fortner M, White J, Gillin JC. (1996). Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB Journal, 10(5):643–653. Open article

Replicated in 42 healthy men: early-night partial sleep deprivation (10 PM–3 AM) reduced NK-cell activity, LAK-cell activity, and IL-2 production. Confirms that even modest sleep disruption impairs the immune responses most relevant to infection resistance.

Van Cauter E, Plat L. (1996). Physiology of growth hormone secretion during sleep. Journal of Pediatrics, 128(5 Pt 2):S32–S37. Open article

Establishes that the dominant pulse of growth-hormone secretion occurs during the first episode of slow-wave sleep. Fragmented or shallow sleep — the kind produced by magnesium depletion and schedule stress — directly limits this anabolic recovery window.

Part IV

Evidence Base & Scientific Team

Key Quantitative Claims

The Mechanism Is Established. The Numbers Are Striking.

Troesch B, et al. (2013). Absorption studies show that phytase significantly increases iron and zinc bioavailability from phytate-rich foods. Food and Nutrition Bulletin, 34(2 Suppl):S90–S101. Open article

Primary source for the iron-bioavailability claim. Reviews 12 human phytase–iron studies and 5 zinc studies; confirms phytase “clearly has a beneficial effect on iron and zinc absorption from phytate-rich foods,” with additional potential for magnesium, calcium, and phosphorus.

Ploumi C, Daskalaki I, Tavernarakis N. (2017). Mitochondrial biogenesis and clearance: a balancing act. FEBS Journal, 284(2):183–195. Open article

Supports the zinc–mitochondrial-function claim. Zinc is a co-factor for multiple mitochondrial enzymes; insufficiency impairs mitochondrial biogenesis and electron-transport-chain function — the cellular basis for aerobic-output decline.

Malo MS, et al. (2010). Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut, 59(11):1476–1484. Open article

Documents IAP's role in reducing endotoxin translocation into systemic circulation — the mechanism behind the “reduced endotoxin translocation” claim.

Abbasi B, et al. (2012). The effect of magnesium supplementation on primary insomnia. Journal of Research in Medical Sciences, 17(12):1161–1169. Open article

Supports the “magnesium-dependent melatonin synthesis and sleep architecture” claim; the magnesium–melatonin co-factor relationship is an established biochemical pathway.

The Animal-Science Foundation

The Mechanism Is Not New. The Application to Human Performance Is.

The four-pillar mechanism rests on 30+ years of animal-nutrition research; the physiology is conserved across mammals, providing the translational basis for human application. Dr. Mike Bedford is the world's most published phytase researcher.

Bedford MR. (2000). Exogenous enzymes in monogastric nutrition — their current value and future benefits. Animal Feed Science and Technology, 86(1–2):1–13. Open article

Review by Dr. Bedford establishing the mechanistic case for exogenous phytase in non-ruminant nutrition — mineral liberation, protein-digestibility improvements, and gut-morphology effects.

Bedford MR, Partridge GG (eds.). (2010). Enzymes in Farm Animal Nutrition (2nd ed.). CABI Publishing. View book

The definitive scientific reference text for enzyme applications in animal nutrition, synthesizing decades of phytase-mechanism research. The conserved mammalian physiology it describes underpins Goodphyte's human application.

Woyengo TA, Cowieson AJ, Adeola O, Nyachoti CM. (2009). Ileal digestibility and endogenous flow of minerals and amino acids: responses to phytic acid ingestion in piglets. British Journal of Nutrition, 102(3):428–433. Open article

Controlled animal study showing that phytic acid reduces ileal digestibility of multiple minerals and amino acids simultaneously — conserved across mammalian digestive physiology.

Selle PH, Ravindran V. (2007). Microbial phytase in poultry nutrition. Animal Feed Science and Technology, 135(1–2):1–41. Open article

Extensive review of phytase mechanisms across decades of poultry research — mineral bioavailability, protein digestibility, gut morphology, and microbiome effects.

About Goodphyte's Human Trials

Goodphyte's controlled human trials are currently in the publication pipeline. Lead author Vaios Svolos (RD, BSc, MSc, PhD), a gastroenterology specialist, is Goodphyte's Clinical Research Lead. When published, these data will provide direct human evidence for the mechanisms described across all four pillars.

For inquiries about the science: goodphyte.com/pages/contact-us